CTBM100C2407: A prospective observational study in cystic fibrosis patients with chronic respiratory Pseudomonas aeruginosa infection treated with TOBI® Podhaler? (tobramycininhalation powder) or other FDA approved inhaled an

Project: Research project

Project Details

StatusActive
Effective start/end date6/1/152/28/22

Funding

  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals Corporation